Impact of the Commercial Introduction of Transcatheter Mitral Valve Repair on Mitral Surgical Practice.
Aged
Aged, 80 and over
Cardiac Catheterization
/ adverse effects
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
/ adverse effects
Humans
Male
Middle Aged
Mitral Valve
/ diagnostic imaging
Mitral Valve Insufficiency
/ diagnostic imaging
Patient Readmission
Postoperative Complications
/ etiology
Program Evaluation
Prosthesis Design
Recovery of Function
Retrospective Studies
Time Factors
Treatment Outcome
MitraClip
halo effect
mitral regurgitation
mitral surgery
transcatheter mitral valve repair
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
07 04 2020
07 04 2020
Historique:
entrez:
7
4
2020
pubmed:
7
4
2020
medline:
9
3
2021
Statut:
ppublish
Résumé
Background There has been uncertainty regarding the effect of transcatheter mitral valve repair (TMVr) with MitraClip on cardiac surgical practice. Our aim was to examine the impact of the commercial introduction of TMVr to a comprehensive mitral program. Methods and Results We evaluated 875 patients (aged 69±14 years; 58% men) who underwent transcatheter or mitral surgical procedures over a 6-year period at our institution. Main outcomes were changes in surgical procedural volume after TMVr introduction and short-term mortality for surgical and TMVr procedures. The numbers of patients treated with MitraClip, isolated mitral repair, and any mitral surgery were 249, 292, and 626 patients, respectively. Compared with surgery, patients with MitraClip were older (aged 82±8 versus 64±12 years;
Identifiants
pubmed: 32248763
doi: 10.1161/JAHA.119.014874
pmc: PMC7428655
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e014874Références
J Am Coll Cardiol. 2017 Jan 31;69(4):381-391
pubmed: 28040318
Ann Thorac Surg. 2006 Sep;82(3):819-26
pubmed: 16928491
J Am Coll Cardiol. 2014 Sep 2;64(9):875-84
pubmed: 25169171
J Am Heart Assoc. 2016 Jul 28;5(8):
pubmed: 27468927
J Am Coll Cardiol. 2014 Oct 28;64(17):1814-9
pubmed: 25443704
J Am Heart Assoc. 2020 Apr 7;9(7):e014874
pubmed: 32248763
Eur Heart J. 2007 Jun;28(11):1358-65
pubmed: 17350971
J Am Coll Cardiol. 2013 Sep 17;62(12):1052-1061
pubmed: 23747789
Ann Thorac Surg. 2010 May;89(5):1385-94
pubmed: 20417750
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1361-71
pubmed: 27388824
J Am Coll Cardiol. 2015 Dec 29;66(25):2844-2854
pubmed: 26718672
Eur J Cardiothorac Surg. 2014 Jan;45(1):139-45; discussion 145
pubmed: 23625450
J Am Coll Cardiol. 2016 Mar 15;67(10):1129-1140
pubmed: 26965532
J Heart Valve Dis. 2015 Nov;24(6):752-759
pubmed: 27997782
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
Circulation. 2013 Apr 9;127(14):1485-92
pubmed: 23459614
J Thorac Cardiovasc Surg. 2006 Feb;131(2):364-70
pubmed: 16434266
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Ann Thorac Surg. 2015 Jun;99(6):1983-90; discussion 1990-1
pubmed: 25865766
J Thorac Cardiovasc Surg. 2012 Aug;144(2):308-12
pubmed: 22698565
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1114-9
pubmed: 25918878
J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185
pubmed: 24603191
J Am Coll Cardiol. 2015 Jul 21;66(3):278-307
pubmed: 26184622
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1093-7
pubmed: 26349597
J Am Coll Cardiol. 2014 Jul 15;64(2):182-92
pubmed: 24184254
J Am Coll Cardiol. 2015 Jul 21;66(3):308-321
pubmed: 26184623